Search research articles
Contact Us
Filters
Showing results (161-170 of 184) with videos related to
Page
of 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 11, 2018
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016
L Marandino, A La Salvia, C Sonetto, et al.
ESMO Open
|
February 26, 2026
Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial
L Paracchini, A Velle, P Di Gennaro, et al.
ESMO Open
|
December 6, 2025
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial
M Bartoletti, A Passarelli, A Fagotti, et al.
British Journal of Cancer
|
November 8, 2023
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
A Leonetti, M Verzè, R Minari, et al.
ESMO Open
|
June 12, 2025
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)
A Rossi, A G Leone, M Lambertini, et al.
ESMO Open
|
August 5, 2021
Skip pattern approach toward the early access of innovative anticancer drugs
G Apolone, A Ardizzoni, A Biondi, et al.
ESMO Open
|
January 4, 2025
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial
B Pellegrino, E D Capoluongo, M Bagnoli, et al.
Current Pharmaceutical Design
|
April 12, 2002
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial
F Perrone, C Gallo, B Daniele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2023
ESMO Guidance for Reporting Oncology real-World evidence (GROW)
L Castelo-Branco, A Pellat, D Martins-Branco, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
ESMO Guidance for Reporting Oncology real-World evidence (GROW)
L Castelo-Branco, A Pellat, D Martins-Branco, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 184) with videos related to
Sort By:
Page
of 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 11, 2018
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016
L Marandino, A La Salvia, C Sonetto, et al.
ESMO Open
|
February 26, 2026
Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial
L Paracchini, A Velle, P Di Gennaro, et al.
ESMO Open
|
December 6, 2025
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial
M Bartoletti, A Passarelli, A Fagotti, et al.
British Journal of Cancer
|
November 8, 2023
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies
A Leonetti, M Verzè, R Minari, et al.
ESMO Open
|
June 12, 2025
Sexual health in cancer care: a narrative review and position statement from the Italian Association of Medical Oncology (AIOM)
A Rossi, A G Leone, M Lambertini, et al.
ESMO Open
|
August 5, 2021
Skip pattern approach toward the early access of innovative anticancer drugs
G Apolone, A Ardizzoni, A Biondi, et al.
ESMO Open
|
January 4, 2025
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial
B Pellegrino, E D Capoluongo, M Bagnoli, et al.
Current Pharmaceutical Design
|
April 12, 2002
Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial
F Perrone, C Gallo, B Daniele, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2023
ESMO Guidance for Reporting Oncology real-World evidence (GROW)
L Castelo-Branco, A Pellat, D Martins-Branco, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
ESMO Guidance for Reporting Oncology real-World evidence (GROW)
L Castelo-Branco, A Pellat, D Martins-Branco, et al.
Page
of 19